Cargando…
HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
INTRODUCTION: Studies have shown that a two-gene ratio (HOXB13:IL17BR) and a five-gene (BUB1B, CENPA, NEK2, RACGAP1, RRM2) molecular grade index (MGI) are predictive of clinical outcomes among early-stage breast cancer patients. In an independent population of lymph node-negative breast cancer patie...
Autores principales: | Habel, Laurel A, Sakoda, Lori C, Achacoso, Ninah, Ma, Xiao-Jun, Erlander, Mark G, Sgroi, Dennis C, Fehrenbacher, Louis, Greenberg, Deborah, Quesenberry, Charles P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672697/ https://www.ncbi.nlm.nih.gov/pubmed/23497539 http://dx.doi.org/10.1186/bcr3402 |
Ejemplares similares
-
Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
por: Jerevall, P-L, et al.
Publicado: (2011) -
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
por: Sgroi, Dennis C., et al.
Publicado: (2013) -
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
por: Habel, Laurel A, et al.
Publicado: (2006) -
MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer
por: Song, Xiaoyu, et al.
Publicado: (2023) -
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting
por: Habel, Laurel A, et al.
Publicado: (2009)